Balyasny Asset Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
NAMI
Balyasny Asset Management's ATRC Position: Q2 2026 in Review
Balyasny Asset Management sold out of AtriCure (ATRC) in Q2 2026, closing a stake of 17,299 shares — an estimated $494K sold.
Balyasny Asset Management first reported a position in ATRC in Q3 2017 and held it in 12 quarters. The position peaked at $22M in Q3 2021. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.
- Balyasny Asset Management reported no remaining AtriCure position as of Q2 2026 after selling out during the quarter.
- Balyasny Asset Management sold 17,299 AtriCure shares in Q2 2026, an estimated $494K.
- Balyasny Asset Management first reported a position in AtriCure in Q3 2017 and held it in 12 quarters.
- Balyasny Asset Management's AtriCure position peaked at $22M in Q3 2021.
- 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.